Serum GDF15 levels correlate to mitochondrial disease severity and myocardial strain, but not to disease progression in adult m.3243A>G carriers

JIMD Reports

Volumn 24, Issue , 2015, Pages 69-81

  Koene, Saskia ^a   de Laat, Paul ^a   van Tienoven, Doorlène H ^a   Weijers, Gert ^a   Vriens, Dennis ^a   Sweep, Fred C G J ^a   Timmermans, Janneke ^a   Kapusta, Livia ^a,b   Janssen, Mirian C H ^a   Smeitink, Jan A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Candidate predictor; Clinical disease severity; Global longitudinal strain; Mitochondrial disease; Myocardial strain

Indexed keywords

EID: 84961290716     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2015_436     Document Type: Chapter

References (29)

1. Association WM (2013) Declaration of Helsinki – ethical principles for medical research involving human subjects. 64th WMA General Assembly, Fortaleza, Brazil
2. Bates MG, Hollingsworth KG, Newman JH et al (2013) Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers. Eur Heart J Cardiovasc Imaging 14:650–658
3. Breit SN, Carrero JJ, Tsai VW et al (2012) Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant 27:70–75
4. Bulten BF, Mavinkurve-Groothuis AM, de Geus-Oei LF et al (2014) Early myocardial deformation abnormalities in breast cancer survivors. Breast Cancer Res Treat 146:127–135
5. de Laat P, Koene S, van den Heuvel LP, Rodenburg RJ, Janssen MC, Smeitink JA (2012) Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A>G mutation. J Inherit Metab Dis 11:1059–1969
6. Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P (2014) Usefulness of growth differentiation factor-15 levels to predict diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 2:01367–01368
7. Emma F, Bertini E, Salviati L, Montini G (2012) Renal involvement in mitochondrial cytopathies. Pediatr Nephrol 27:539–550
8. Hirano M, Konishi K, Arata N et al (2002) Renal complications in a patient with A-to-G mutation of mitochondrial DNA at the 3243 position of leucine tRNA. Intern Med 41:113–118
9. Ho JE, Mahajan A, Chen MH et al (2012) Clinical and genetic correlates of growth differentiation factor 15 in the community. Clin Chem 58:1582–1591
10. Ho JE, Hwang SJ, Wollert KC et al (2013) Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem 59:1613–1620
11. Hollingsworth KG, Gorman GS, Trenell MI et al (2012) Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A>G mutation and correlates with mutation load. Neuro-muscul Disord 22:592–596
12. Izumiya Y, Hanatani S, Kimura Y et al (2014) Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction. Can J Cardiol 30:338–344
13. Kalko SG, Paco S, Jou C et al (2014) Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. BMC Genomics 15:91
14. Kempf T, Wollert KC (2013) Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome. Crit Care 17:173
15. Koene S, de Laat P, van Tienoven DH et al (2014) Serum FGF21 levels in adult m.3243A>G carriers: clinical implications. Neurology 6:125–133
16. Lee SK, Kim J, Kim HD, Lee JS, Lee YM (2010) Initial experiences with proton MR spectroscopy in treatment monitoring of mitochondrial encephalopathy. Yonsei Med J 51:672–675
17. Lok SI, Winkens B, Goldschmeding R et al (2012) Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support. Eur J Heart Fail 14:1249–1256
18. Mayeux R (2004) Biomarkers: potential uses and limitations. NeuroRx 1:182–188
19. Montoro-Garcia S, Hernandez-Romero D, Jover E et al (2012) Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy. Eur J Intern Med 23:169–174
20. Moore AG, Brown DA, Fairlie WD et al (2000) The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab 85:4781–4788
21. Pfeffer G, Horvath R, Klopstock T et al (2013) New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol 9:474–481
22. Plana JC, Galderisi M, Barac A et al (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 15:1063–1093
23. Schaefer AM, Phoenix C, Elson JL, McFarland R, Chinnery PF, Turnbull DM (2006) Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology 66:1932–1934
24. St John Sutton M, Ky B, Regner SR et al (2014) Longitudinal strain in Friedreich Ataxia: a potential marker for early left ventricular dysfunction. Echocardiography 31:50–57
25. Suomalainen A (2011) Biomarkers for mitochondrial respiratory chain disorders. J Inherit Metab Dis 34:277–282
26. Trovik J, Salvesen HB, Cuppens T, Amant F, Staff AC (2014) Growth differentiation factor-15 as biomarker in uterine sarcomas. Int J Gynecol Cancer 24:252–259
27. Xu X, Li Z, Gao W (2011) Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside. Biomarkers 16:466–475
28. Yang CZ, Ma J, Zhu DW et al (2014) GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma. Ann Oncol 24:24
29. Yatsuga S, Koga Y (2014) Growth differentiation factor 15 and fibroblast growth factor 21: novel biomarkers for mitochondrial diseases United Mitochondrial Disease Foundation Conference 2014